Cross-Border Impact Ventures is a women-led impact venture capital firm based in Toronto that invests in health technology companies addressing the needs of women, children, and adolescents globally. The firm's first fund closed with over $90 million USD in commitments.
50% of their portfolio is in Healthcare. Their most common stage is series-a (50% of deals). Average disclosed round size is $14.9M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$90M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| OOXcan | Series A | $11M | Jan 2025 |
 OncoLens | Series B | $16M | Oct 2024 |
 Raydiant Oximetry | Series A | $7.5M | Jun 2024 |
 Pendulum | Unknown | $22M | — |
 Oxford Cancer Analytics | Series A | $11M | — |
 Pendulum Systems | Unknown | $22M | — |
Top Co-Investors
Lowercarbon Capital2 shared
Decisive Point2 shared
RH Capital1 shared
DCVC1 shared
Plug and Play Tech Center1 shared
Macmillan Cancer Support1 shared
Civilization Ventures1 shared
Martin Ventures1 shared
Last updated: 8 September 2026